Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Micell Technologies Inc patents


Recent patent applications related to Micell Technologies Inc. Micell Technologies Inc is listed as an Agent/Assignee. Note: Micell Technologies Inc may have other listings under different names/spellings. We're not affiliated with Micell Technologies Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Micell Technologies Inc-related inventors


 new patent  Implantable device

An implantable device including a sensing element, transmitter and power element is disclosed. The device may allow for monitoring of one or more body conditions in a minimally invasive manner, while a receiver may receive such information. ... Micell Technologies Inc

Polymer coatings containing drug powder of controlled morphology

A method for depositing a coating comprising a polymer and pharmaceutical agent on a substrate, comprising the following steps: discharging at least one pharmaceutical agent in a therapeutically desirable morphology in dry powder form through a first orifice; discharging at least one polymer in dry powder form through a second orifice; depositing the polymer and/or pharmaceutical particles onto said substrate, wherein an electrical potential is maintained between the substrate and the pharmaceutical and/or polymer particles, thereby forming said coating; and sintering said coating under conditions that do not substantially modify the morphology of said pharmaceutical agent.. . ... Micell Technologies Inc

Prolonged drug-eluting products

A drug-eluting product is disclosed comprising an at least partially bioabsorbable element and an active pharmaceutical agent having a morphology, a solubility, and an average particle size which are selected so that the active pharmaceutical agent continues to dissolve during the biodegradation of the bioabsorbable element. The morphology is a crystalline, semi-crystalline or amorphous morphology, the solubility is less than 100 μg/ml and the average particle size is grater that about 100 nm.. ... Micell Technologies Inc

Biodegradable polymers

Provided herein is a composition comprising a poly(alpha-hydroxycarboxylic acid) substantially free of acidic impurities wherein the poly(alpha-hydroxycarboxylic acid) is selected from poly(d,l-lactic-co-glycolic acid), poly(l-lactic acid), poly(d-lactic acid) and poly(d,l-lactic acid). Also provided is a device comprising: a substrate, and a coating wherein the coating comprises poly(d,l-lactic-co-glycolic acid) substantially free of acidic impurities.. ... Micell Technologies Inc

Stents having biodegradable layers

A method for preparing a laminate coronary stent comprising: providing a stent framework; and depositing a plurality of layers on said stent framework to form said laminate coronary stent; wherein at least one of said layers comprises a bioabsorbable polymer.. . ... Micell Technologies Inc

Stents having bioabsorbable layers

Provided herein is a device comprising: a. Stent; b. ... Micell Technologies Inc

Coatings containing multiple drugs

A method for depositing a coating comprising a polymer and at least two pharmaceutical agents on a substrate, comprising the following steps: providing a stent framework; depositing on said stent framework a first layer comprising a first pharmaceutical agent; depositing a second layer comprising a second pharmaceutical agent; wherein said first and second pharmaceutical agents are selected from two different classes of pharmaceutical agents.. . ... Micell Technologies Inc

Macrolide dosage forms

Provided is a drug delivery composition comprising at least one polymer and at least one active agent; wherein the active agent is present in crystalline form on at least one region of an outer surface of the composition and wherein active agent surface content is adjusted to provide a selected active agent release profile.. . ... Micell Technologies Inc

Drug delivery medical device

Provided is a coated implantable medical device, comprising: a substrate; and a coating disposed on said substrate, wherein said coating comprises at least one polymer and at least one pharmaceutical agent in a therapeutically desirable morphology and/or at least one active biological agent and optionally, one or more pharmaceutical carrying agents; wherein substantially all of pharmaceutical agent and/or active biological agent remains within said coating and on said substrate until the implantable device is deployed at an intervention site inside the body of a subject and wherein upon deployment of said medical device in the body of said subject a portion of said pharmaceutical agent and/or active biological agent is delivered at said intervention site along with at least a portion of said polymer and/or a at least a portion of said pharmaceutical carrying agents.. . ... Micell Technologies Inc

Drug delivery medical device

Provided is a coated implantable medical device, comprising: a substrate; and a coating disposed on the substrate, wherein the coating comprises at least one polymer and at least one pharmaceutical agent in a therapeutically desirable morphology and/or at least one active biological agent and optionally, one or more pharmaceutical carrying agents; wherein substantially all of pharmaceutical agent and/or active biological agent remains within the coating and on the substrate until the implantable device is deployed at an intervention site inside the body of a subject and wherein upon deployment of the medical device in the body of the subject a portion of the pharmaceutical agent and/or active biological agent is delivered at the intervention site along with at least a portion of the polymer and/or a at least a portion of the pharmaceutical carrying agents.. . ... Micell Technologies Inc

Biopharma application of micell technology

Drug delivery systems are disclosed which include a drug in dry powder form and a biodegradable or metabolizable carrier having an average particle size of less than about 1 mm for delivery of the drug to a particular location in the body and for providing for the timed elution of the drug at that location, preferably by exhibiting a linear drug elution profile for a sustained drug release period of at least 30 days. Methods for manufacturing these drug delivery systems are also disclosed.. ... Micell Technologies Inc

Biodegradable polymers

Provided herein is a composition comprising a poly(alpha-hydroxycarboxylic acid) substantially free of acidic impurities wherein the poly(alpha-hydroxycarboxylic acid) is selected from poly(d,l-lactic-co-glycolic acid), poly(l-lactic acid), poly(d-lactic acid) and poly(d,l-lactic acid). Also provided is a device comprising: a substrate, and a coating wherein the coating comprises poly(d,l-lactic-co-glycolic acid) substantially free of acidic impurities.. ... Micell Technologies Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Micell Technologies Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Micell Technologies Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###